Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: The EPIC-InterAct case-cohort study

The Lancet Diabetes and Endocrinology

Volumn 2, Issue 10, 2014, Pages 810-818

  Forouhi, Nita G ^a   Koulman, Albert ^b   Sharp, Stephen J ^a   Imamura, Fumiaki ^a   Kröger, Janine ^c   Schulze, Matthias B ^c   Crowe, Francesca L ^d   Huerta, José María ^e,f   Guevara, Marcela ^f,g   Beulens, Joline W J ^h   van Woudenbergh, Geertruida J ⁱ   Wang, Laura ^b   Summerhill, Keith ^b   Griffin, Julian L ^b   Feskens, Edith J M ⁱ   Amiano, Pilar ^f,j,k   Boeing, Heiner ^c   Clavel Chapelon, Françoise ^l,m,n   Dartois, Laureen ^l,m,n   Fagherazzi, Guy ^l,m,n   Franks, Paul W ^o,p   Gonzalez, Carlos ^q   Jakobsen, Marianne Uhre ^r   Kaaks, Rudolf ^s   Key, Timothy J ^d   Khaw, Kay Tee ^a   Kühn, Tilman ^s   Mattiello, Amalia ^t   Nilsson, Peter M ^o   Overvad, Kim ^r,u   Pala, Valeria ^v   Palli, Domenico ^w   Quirós, J Ramón ^x   Rolandsson, Olov ^p   Roswall, Nina ^y   Sacerdote, Carlotta ^z,aa   Sánchez, María José ^f,ab,ac   Slimani, Nadia ^ad   Spijkerman, Annemieke M W ^ae   Tjonneland, Anne ^y   Tormo, Maria José ^e,f,af   Tumino, Rosario ^ag,ah   van der A, Daphne L ^ae   van der Schouw, Yvonne T ^h   Langenberg, Claudia ^a   Riboli, Elio ^ai   Wareham, Nicholas J ^a   more..

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b MRC HUMAN NUTRITION RESEARCH   (United Kingdom)

^c GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^d UNIVERSITY OF OXFORD   (United Kingdom)

^e DEPARTMENT OF EPIDEMIOLOGY   (Spain)

^f CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^g INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^h UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

ⁱ WAGENINGEN UNIVERSITY   (Netherlands)

^j Public Health Division of Gipuzkoa   (Spain)

^k BIODONOSTIA HEALTH RESEARCH INSTITUTE   (Spain)

^l CENTRE FOR RESEARCH IN EPIDEMIOLOGY AND POPULATION HEALTH   (France)

^m UNIVERSITÉ PARIS SACLAY   (France)

ⁿ INSTITUT GUSTAVE ROUSSY   (France)

^o LUND UNIVERSITY   (Sweden)

^p UMEÅ UNIVERSITY   (Sweden)

^q CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^r AARHUS UNIVERSITY   (Denmark)

^s GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^t UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^u AALBORG UNIVERSITY HOSPITAL   (Denmark)

^v NATIONAL CANCER INSTITUTE   (Italy)

^w CANCER RESEARCH AND PREVENTION INSTITUTE ISPO   (Italy)

^x Public Health Directorate   (Spain)

^y DANISH CANCER SOCIETY RESEARCH CENTER   (Denmark)

^z CITTÀ DELLA SALUTE E DELLA SCIENZA HOSPITAL   (Italy)

^aa Human Genetics Foundation   (Italy)

^ab ANDALUSIAN SCHOOL OF PUBLIC HEALTH   (Spain)

^ac Instituto De Investigación Biosanitaria de Granada Ibs GRANADA   (Spain)

^ad INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^ae NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^af UNIVERSITY OF MURCIA   (Spain)

^ag Dipartimento di Prevenzione Medica   (Italy)

^ah Aire Onlus   (Italy)

^ai IMPERIAL COLLEGE LONDON   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A DESATURASE 1; ARACHIDIC ACID; BEHENIC ACID; HEPTADECANOIC ACID; LIGNOCERIC ACID; MYRISTIC ACID; PALMITIC ACID; PENTADECANOIC ACID; SATURATED FATTY ACID; STEARIC ACID; TRICOSANOIC ACID; UNCLASSIFIED DRUG; FATTY ACID; PHOSPHOLIPID;

ADULT; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FOLLOW UP; GAS CHROMATOGRAPHY; HUMAN; INCIDENCE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PHOSPHOLIPID BLOOD LEVEL; PHOSPHOLIPID METABOLISM; PROSPECTIVE STUDY; SENSITIVITY ANALYSIS; BLOOD; CASE CONTROL STUDY; DIABETES MELLITUS, TYPE 2; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; FATTY ACIDS; FEMALE; HUMANS; MALE; MIDDLE AGED; PHOSPHOLIPIDS; PROSPECTIVE STUDIES;

EID: 84922235687     PISSN: 22138587     EISSN: 22138595     Source Type: Journal    
DOI: 10.1016/S2213-8587(14)70146-9     Document Type: Article

References (30)

1. Eyre H, Kahn R, Robertson RM, et al. Preventing cancer, cardiovascular disease, and diabetes: a common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association. Circulation 2004, 109:3244-3255.
2. Micha R, Mozaffarian D Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence. Lipids 2010, 45:893-905.
3. Tinker LF, Bonds DE, Margolis KL, et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Arch Intern Med 2008, 168:1500-1511.
4. Sluijs I, Forouhi NG, Beulens JW, et al. The amount and type of dairy product intake and incident type 2 diabetes: results from the EPIC-InterAct Study. Am J Clin Nutr 2012, 96:382-390.
5. O'Connor LM, Lentjes MA, Luben RN, et al. Dietary dairy product intake and incident type 2 diabetes: a prospective study using dietary data from a 7-day food diary. Diabetologia 2014, 57:909-917.
6. Hodson L, Skeaff CM, Fielding BA Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog Lipid Res 2008, 47:348-380.
7. Wolk A, Vessby B, Ljung H, Barrefors P Evaluation of a biological marker of dairy fat intake. Am J Clin Nutr 1998, 68:291-295.
8. Smedman AE, Gustafsson IB, Berglund LG, Vessby BO Pentadecanoic acid in serum as a marker for intake of milk fat: relations between intake of milk fat and metabolic risk factors. Am J Clin Nutr 1999, 69:22-29.
9. Hudgins LC, Hellerstein M, Seidman C, et al. Human fatty acid synthesis is stimulated by a eucaloric low fat, high carbohydrate diet. J Clin Invest 1996, 97:2081-2091.
10. King IB, Lemaitre RN, Kestin M Effect of a low-fat diet on fatty acid composition in red cells, plasma phospholipids, and cholesterol esters: investigation of a biomarker of total fat intake. Am J Clin Nutr 2006, 83:227-236.
11. Hudgins LC, Seidman CE, Diakun J, Hirsch J Human fatty acid synthesis is reduced after the substitution of dietary starch for sugar. Am J Clin Nutr 1998, 67:631-639.
12. Siler SQ, Neese RA, Hellerstein MK De novo lipogenesis, lipid kinetics, and whole-body lipid balances in humans after acute alcohol consumption. Am J Clin Nutr 1999, 70:928-936.
13. Hodson L, McQuaid SE, Karpe F, Frayn KN, Fielding BA Differences in partitioning of meal fatty acids into blood lipid fractions: a comparison of linoleate, oleate, and palmitate. Am J Physiol Endocrinol Metab 2009, 296:E64-E71.
14. Hellerstein MK, Schwarz JM, Neese RA Regulation of hepatic de novo lipogenesis in humans. Annu Rev Nutr 1996, 16:523-557.
15. Kroger J, Zietemann V, Enzenbach C, et al. Erythrocyte membrane phospholipid fatty acids, desaturase activity, and dietary fatty acids in relation to risk of type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study. Am J Clin Nutr 2011, 93:127-142.
16. Patel PS, Sharp SJ, Jansen E, et al. Fatty acids measured in plasma and erythrocyte-membrane phospholipids and derived by food-frequency questionnaire and the risk of new-onset type 2 diabetes: a pilot study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk cohort. Am J Clin Nutr 2010, 92:1214-1222.
17. Krachler B, Norberg M, Eriksson JW, et al. Fatty acid profile of the erythrocyte membrane preceding development of Type 2 diabetes mellitus. Nutr Metab Cardiovasc Dis 2008, 18:503-510.
18. Hodge AM, English DR, O'Dea K, et al. Plasma phospholipid and dietary fatty acids as predictors of type 2 diabetes: interpreting the role of linoleic acid. Am J Clin Nutr 2007, 86:189-197.
19. Wang L, Folsom AR, Zheng ZJ, Pankow JS, Eckfeldt JH Plasma fatty acid composition and incidence of diabetes in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 2003, 78:91-98.
20. Mozaffarian D, de Oliveira Otto MC, Lemaitre RN, et al. Trans-palmitoleic acid, other dairy fat biomarkers, and incident diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 2013, 97:854-861.
21. Laaksonen DE, Lakka TA, Lakka HM, et al. Serum fatty acid composition predicts development of impaired fasting glycaemia and diabetes in middle-aged men. Diabet Med 2002, 19:456-464.
22. Langenberg C, Sharp S, Forouhi NG, et al. Design and cohort description of the InterAct Project: an examination of the interaction of genetic and lifestyle factors on the incidence of type 2 diabetes in the EPIC Study. Diabetologia 2011, 54:2272-2282.
23. Wang LY, Summerhill K, Rodriguez-Canas C, et al. Development and validation of a robust automated analysis of plasma phospholipid fatty acids for metabolic phenotyping of large epidemiological studies. Genome Med 2013, 5:39.
24. Slimani N, Deharveng G, Unwin I, et al. The EPIC nutrient database project (ENDB): a first attempt to standardize nutrient databases across the 10 European countries participating in the EPIC study. Eur J Clin Nutr 2007, 61:1037-1056.
25. Reddy JK, Hashimoto T Peroxisomal beta-oxidation and peroxisome proliferator-activated receptor alpha: an adaptive metabolic system. Annu Rev Nutr 2001, 21:193-230.
26. Hodson L, Fielding BA Stearoyl-CoA desaturase: rogue or innocent bystander?. Prog Lipid Res 2013, 52:15-42.
27. Chowdhury R, Warnakula S, Kunutsor S, et al. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med 2014, 160:398-406.
28. Postic C, Girard J The role of the lipogenic pathway in the development of hepatic steatosis. Diabetes Metab 2008, 34:643-648.
29. Maedler K, Spinas GA, Dyntar D, et al. Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function. Diabetes 2001, 50:69-76.
30. Park DY, Ahn YT, Park SH, et al. Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity. PLoS One 2013, 8:e59470.